← Leaderboards
Sasanka S Chukkapalli
University Of Florida
$316,735
Attributed
$335,124
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $246.4K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$796,582 · 3
By mechanism
R21$489,041 · 2
R03$307,541 · 1
Top collaborators
- Kirk Edward Hevener4 shared
- Julian G Hurdle4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Ann Progulske-Fox$13,071,613
- Kesavalu Naidu Lakshmyya$4,955,367
- Christian Jobin$16,517,406
- Thomas A Brown$1,582,295
- Jia Chang$1,800,074
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventOrganismInvadedPorphyromonas GingivalisVirulencePathogenesisEnvironmentInsightPathogenPeriodontal DiseasesTechnologyTooth LossSystemic DiseasePathogenicityAnimal ModelChronicFutureGingivaMessenger RnaAtherosclerosisAntimicrobial ResistanceAnalogAntimicrobialBone Loss
Grant awards (7)
Evaluation of a microbiota-sparing therapeutic concept for periodontal disease, involving removal of pathogenic Porphyromonas and Fusobacterium$191,250
R21 · FY2025 · DE
ConProject-001$27,583
R21 · FY2025 · DE
Evaluation of a microbiota-sparing therapeutic concept for periodontal disease, involving removal of pathogenic Porphyromonas and Fusobacterium$27,583
R21 · FY2025 · DE
Evaluation of a microbiota-sparing therapeutic concept for periodontal disease, involving removal of pathogenic Porphyromonas and Fusobacterium$242,625
R21 · FY2024 · DE
Integrated transcriptomics and metabolomics approach to define pathogenicity of P.gingivalis$146,190
R03 · FY2021 · DE · contact PI
Integrated transcriptomics and metabolomics approach to define pathogenicity of P.gingivalis$8,851
R03 · FY2021 · DE · contact PI
Integrated transcriptomics and metabolomics approach to define pathogenicity of P.gingivalis$152,500
R03 · FY2020 · DE · contact PI